col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


66 Results       Page 1

 [1] 
Elsevier: Microbes and Infection
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―23 Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals? Sharvan Sehrawat, Nikolaus Osterrieder, D.Scott Schmid, Barry T. Rouse
2 [GO] 2022―Nov―16 SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection Damien Jacot, Urs von Rotz, Céline Pellaton, Fanny Blondet, Oriane Aebischer, Matthieu Perreau, et al. (+4)
3 [GO] 2022―Oct―12 Mycobiome profiling of nasopharyngeal region of SARS-CoV-2 infected individuals Abhishek Gupta, Shivang Bhanushali, Rajesh Karyakarte, Suvarna Joshi, Rashmita Das, Yogesh Shouche, Avinash Sharma
4 [GO] 2022―Sep―09 Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines Yu-An Kung, Sheng-Yu Huang, Chung-Guei Huang, Kuan-Ting Liu, Peng-Nien Huang, Kar-Yee Yu, et al. (+10)
5 [GO] 2022―Aug―24 COVID-19 and Fungal Infections: A Double Debacle Sara Mina, Hajar Yaakoub, Cédric Annweiler, Vincent Dubée, Nicolas Papon
6 [GO] 2022―Apr―20 Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection Purwa Doke, Jayshree Sachin Gothankar, Prakash Prabhakarrao Doke, Milind Madhukar Kulkarni, Kiran Kishanrao Khalate, Shubham Shrivastava, et al. (+2)
7 [GO] 2022―Apr―04 Humoral Immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients Emanuela Anastasi, Marco Marziali, Adele Preziosi, Elena Berardelli, Anna Annunziata Losardo, Michela Ribersani, et al. (+4)
8 [GO] 2022―Feb―28 Miller-Fisher syndrome associated with SARS-CoV-2: a case report Dr L. Faulkner, Dr S. Scott, Dr NJ. Flint
9 [GO] 2022―Feb―02 Clinical and genomic data of sars-cov-2 detected in maternal-fetal interface during the first wave of infection in brazil Maria de Fátima Carvalho Ferreira, Janeth Aracely Ramirez Pavon, Amanda Colichio Bini Napoleão, Gláucia Maria Duarte Preza Figueiredo, Patricia Cristina Borges Florêncio, Rayssa Basílio dos Santos Arantes, et al. (+6)
10 [GO] 2022―Jan―31 Application experience of a rapid nucleic acid detection system for COVID-19 Qing Ye, Dezhao Lu, Ting Zhang, Jianhua Mao, Shiqiang Shang
11 [GO] 2021―Dec―03 Impact of non-pharmaceutical interventions during the COVID-19 pandemic on common childhood respiratory viruses - A epidemiological study based on hospital data Qing Ye, Huihui Liu
12 [GO] 2021―Nov―25 NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity Saiful Amin, Salma Aktar, Md. Mijanur Rahman, Mohammed Mehadi Hassan Chowdhury
13 [GO] 2021―Sep―15 Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals Emmanuel Sunday Okeke, Martins Obinna Ogugofor, Ndidi Ethel Nkwoemeka, Ekene John Nweze, Charles Obinwanne Okoye
14 [GO] 2021―Aug―21 Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types Abhishek Gupta, Rajesh Karyakarte, Suvarna Joshi, Rashmita Das, Kunal Jani, Yogesh Shouche, Avinash Sharma
15 [GO] 2021―Aug―19 The COVID-19 epidemic and other notifiable infectious diseases in China Bing-ke Bai, Qi-yu Jiang, Jun Hou
16 [GO] 2021―Jun―18 Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo Naveen Yadav, Preeti Vishwakarma, Ritika Khatri, Gazala Siddqui, Amit Awasthi, Shubbir Ahmed, Sweety Samal
17 [GO] 2021―Jun―12 The role of sexual dimorphism in susceptibility to SARS-CoV-2 infection, disease severity, and mortality: facts, controversies and future perspectives Stavroula Pegiou, Elpiniki Rentzeperi, Theocharis Koufakis, Symeon Metallidis, Kalliopi Kotsa
18 [GO] 2021―Jun―11 Airborne infection with Covid-19? A historical look at a current controversy Igor J. Polianski
19 [GO] 2021―May―20 Development of leading first-generation vaccines against SARS-CoV-2 Pin-Yu Perera, Liyanage P. Perera
20 [GO] 2021―Apr―19 Management of COVID-19: Current Status and Future Prospects Md Alamgir Kabir, Rajib Ahmed, Rasheduzzaman Chowdhury, Sheikh Muhammad Asher Iqbal, Ramasamy Paulmurugan, Utkan Demirci, Waseem Asghar
21 [GO] 2021―Mar―27 Had COVID-19 spread in the community before the first confirmed case in Nagasaki, Japan? Norihito Kaku, Kenji Ota, Daisuke Sasaki, Norihiko Akamatsu, Naoki Uno, Kei Sakamoto, et al. (+5)
22 [GO] 2021―Mar―20 “Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering.” A. Farina, R. Labriola, C. Ialongo, M. Suppa, V. Viggiani, M. Lucarelli, et al. (+2)
23 [GO] 2021―Mar―18 Prolonged Viral Shedding and Antibody Persistence in Patients with COVID-19 Fatemeh Fotouhi, Mostafa Salehi-Vaziri, Behrokh Farahmand, Ehsan Mostafavi, Mohammad Hassan Pouriayevali, Tahmineh Jalali, et al. (+9)
24 [GO] 2021―Mar―18 COVID-19 Vaccine Decisions: Considering the Choices and Opportunities Peter J. Hotez, Tasmiah Nuzhath, Timothy Callaghan, Brian Colwell
25 [GO] 2021―Mar―06 Bacterial and fungal co-infections among COVID-19 patients in intensive care unit Siyuan Yang, Mingxi Hua, Xinzhe Liu, Chunjing Du, Lin Pu, Pan Xiang, et al. (+2)
26 [GO] 2021―Mar―02 Recurrence of COVID-19 after recovery ? A case series in health care workers, France Souheil Zayet, Pierre-Yves Royer, Lynda Toko, Alix Pierron, Vincent Gendrin, Timothée Klopfenstein
27 [GO] 2021―Feb―03 Personalized Stewardship and Interdisciplinarity: Key Elements of COVID-19 Tommaso Lupia, Silvia Corcione, Francesco G. De Rosa
28 [GO] 2021―Jan―20 Could targeting immunometabolism be a way to control the burden of COVID-19 infection? Engin Berber, Deepak Sumbria, Barry T. Rouse
29 [GO] 2021―Jan―14 COVID-19: Disease, or no disease? - that is the question. It’s the dose stupid! Sharvan Sehrawat, Barry T. Rouse
30 [GO] 2020―Nov―07 Digging the Rabbit Hole, COVID-19 Edition: Anti-Vaccine Themes and the Discourse Around COVID-19 Tara C. Smith, Dorit Rubinstein Reiss
31 [GO] 2020―Oct―14 SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector Lena Faust, Alexandra J. Zimmer, Mikashmi Kohli, Senjuti Saha, Jody Boffa, Marlon L. Bayot, et al. (+21)
32 [GO] 2020―Oct―10 COVID-19: comparative clinical features and outcome in 114 patients with or without pneumonia (Nord Franche-Comte Hospital, France) N’dri Juliette Kadiane-Oussou, Timothee Klopfenstein, Pierre-Yves Royer, Lynda Toko, Vincent Gendrin, Souheil Zayet
33 [GO] 2020―Oct―10 Non-synonymous Mutations of SARS-CoV-2 Leads Epitope Loss and Segregates its Variants Aayatti Mallick Gupta, Jaydeb Chakrabarti, Sukhendu Mandal
34 [GO] 2020―Sep―22 Low-impact social distancing interventions to mitigate local epidemics of SARS-CoV-2 Michael L. Jackson
35 [GO] 2020―Sep―19 Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system Nina Marí G.P. de Queiroz, Fabio V. Marinho, Marcelo A. Chagas, Luciana C.C. Leite, E. Jane Homan, Mariana T.Q. de Magalhães, Sergio C. Oliveira
36 [GO] 2020―Sep―07 Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses Damien Jacot, Gilbert Greub, Katia Jaton, Onya Opota
37 [GO] 2020―Sep―04 Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis Flavio De Maio, Ettore Lo Cascio, Gabriele Babini, Michela Sali, Stefano Della Longa, Bruno Tilocca, et al. (+5)
38 [GO] 2020―Jul―09 Opinion: Does the hygiene hypothesis apply to COVID-19 susceptibility? Sharvan Sehrawat, Barry T. Rouse
39 [GO] 2020―Jun―26 Coronavirus Vaccine-Associated Lung Immunopathology-What Is The Significance? Maria Elena Bottazzi, Ulrich Strych, Peter J. Hotez, David B. Corry
40 [GO] 2020―Jun―24 Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19 Jeremia M. Coish, Adam J. MacNeil
41 [GO] 2020―Jun―20 Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19) Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, Pierre-Yves Royer, Marie Bossert, Vincent Gendrin, et al. (+8)
42 [GO] 2020―Jun―16 Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster Souheil Zayet, N’dri Juliette Kadiane-Oussou, Quentin Lepiller, Hajer Zahra, Pierre-Yves Royer, Lynda Toko, et al. (+2)
43 [GO] 2020―May―21 Immunoinformatic analysis of the SARS-CoV-2 Envelope protein as a strategy to assess cross-protection against COVID-19 Bruno Tilocca, Alessio Soggiu, Maurizio Sanguinetti, Gabriele Babini, Flavio De Maio, Domenico Britti, et al. (+4)
44 [GO] 2020―May―18 Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study Zhihua Lv, Shaohua Cheng, Juan Le, Jingtao Huang, Lina Feng, Binghong Zhang, Yan Li
45 [GO] 2020―May―18 A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients Lei Liu, Wanbing Liu, Yaqiong Zheng, Xiaojing Jiang, Guomei Kou, Jinya Ding, et al. (+19)
46 [GO] 2020―May―16 Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency Shawn J. Green
47 [GO] 2020―May―13 Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season Chao Jiang, Xingang Yao, Yulin Zhao, Jianmin Wu, Pan Huang, Chunhua Pan, et al. (+2)
48 [GO] 2020―May―11 From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development Cuiqing Ma, Shan Su, Jiachao Wang, Lin Wei, Lanying Du, Shibo Jiang
49 [GO] 2020―May―07 Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China Yan Ma, Qing-nan Xu, Feng-li Wang, Xiao-man Ma, Xiao-yan Wang, Xiao-guo Zhang, Zhong-fa Zhang
50 [GO] 2020―May―06 The Forrest Gump approach to preventing severe COVID-19 - reverse the predisposing pro-inflammatory state with exercise Chris Kenyon
51 [GO] 2020―May―06 Current development of COVID-19 diagnostics, vaccines and therapeutics Naru Zhang, Chaoqun Li, Yue Hu, Kangchen Li, Jintian Liang, Lili Wang, et al. (+2)
52 [GO] 2020―May―06 Could nasal nitric oxide help to mitigate the severity of COVID-19? Jan Martel, Yun-Fei Ko, John D. Young, David M. Ojcius
53 [GO] 2020―Apr―30 Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes Mario Adán Moreno-Eutimio, Constantino López-Macías, Rodolfo Pastelin-Palacios
54 [GO] 2020―Apr―22 The fate of house cats during the COVID-19 pandemic Tianyue Gao, Xingchen Pan, Chungen Pan
55 [GO] 2020―Apr―17 Chloroquine Paradox May Cause More Damage Than Help Fight COVID-19 Anuj Sharma
56 [GO] 2020―Apr―17 The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement Peter J. Hotez, Maria Elena Bottazzi, David B. Corry
57 [GO] 2020―Apr―14 Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses Bruno Tilocca, Alessio Soggiu, Maurizio Sanguinetti, Vincenzo Musella, Domenico Britti, Luigi Bonizzi, et al. (+2)
58 [GO] 2020―Apr―08 Emergency response to the outbreak of COVID-19: the Korean case Kyoo-Man Ha
59 [GO] 2020―Apr―05 It is too soon to attribute ADE to COVID-19 Anuj Sharma
60 [GO] 2020―Mar―19 Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 Ye Qiu, Yuan-Bo Zhao, Qiong Wang, Jin-Yan Li, Zhi-Jian Zhou, Ce-Heng Liao, Xing-Yi Ge
61 [GO] 2020―Mar―17 Molecular basis of COVID-19 relationships in different species: a one health perspective Bruno Tilocca, Alessio Soggiu, Vincenzo Musella, Domenico Britti, Maurizio Sanguinetti, Andrea Urbani, Paola Roncada
62 [GO] 2020―Feb―22 Is COVID-19 Receiving ADE From Other Coronaviruses? Jason A. Tetro
63 [GO] 2020―Feb―21 Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases Xingchen Pan, David M. Ojcius, Tianyue Gao, Zhongsheng Li, Chunhua Pan, Chungen Pan
64 [GO] 2020―Feb―21 The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future Jin-Yan Li, Zhi You, Qiong Wang, Zhi-Jian Zhou, Ye Qiu, Rui Luo, Xing-Yi Ge
65 [GO] 2020―Feb―20 Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses Jieliang Chen
66 [GO] 2020―Feb―01 Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China Fei Yu, Lanying Du, David M. Ojcius, Chungen Pan, Shibo Jiang
 [1] 

66 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec